Products Ibrutinib + Venetoclax
Ibrutinib + Venetoclax Phase 1/2 Completed ⚡ Active Refractory Follicular Lymphoma
Refractory Follicular Lymphoma, Relapsed Follicular Lymphoma
Mar 1, 2017 → Mar 7, 2024
About Ibrutinib + Venetoclax Ibrutinib + Venetoclax is a phase 1/2 stage product being developed by AbbVie for Refractory Follicular Lymphoma. The current trial status is completed. This product is registered under clinical trial identifier NCT02956382. Target conditions include Refractory Follicular Lymphoma, Relapsed Follicular Lymphoma.
Clinical Trials (3) NCT ID Phase Status Start Completion Indication NCT04477486 Phase 2 Completed Sep 23, 2020 May 28, 2025 Mantle Cell Lymphoma (MCL) NCT04273139 Phase 2 Active Jul 9, 2020 Feb 1, 2028 Waldenstrom Macroglobulinemia NCT02956382 Phase 1/2 Completed Mar 1, 2017 Mar 7, 2024 Refractory Follicular Lymphoma
Product Company Stage Hype Score Abemaciclib, dexamethasone, ixazomib, pomalidomide + Enasidenib, dexamethasone, ixazomib, pomalidomide + Cobimetinib, dexamethasone, ixazomib, pomalidomide + Erdafitinib, dexamethasone, ixazomib, pomalidomide + Venetoclax, dexamethasone, ixazomib, pomalidomide + Daratumumab, dexamethasone, ixazomib, pomalidomide + Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide + Selinexor, dexamethasone, ixazomib, pomalidomide Eli Lilly Phase 1/2 agenT-797 MiNK Therapeutics Phase 1 eFT508 + Avelumab eFFECTOR Therapeutics Phase 2 CT-P44(Daratumumab) + Darzalex Faspro(Daratumumab) Celltrion Phase 3 Valemetostat Tosylate Daiichi Sankyo Phase 2 Enzalutamide Astellas Pharma Phase 2 ASP1650 Astellas Pharma Phase 2 YM598 Astellas Pharma Phase 2 erlotinib + etoposide Astellas Pharma Phase 2 Mitoxantrone Hydrochloride Liposome & Enlonstobart Sun Pharmaceutical Phase 1/2 Lenvatinib + Everolimus Eisai Phase 1/2 perampanel + perampanel + perampanel + Placebo Eisai Phase 3 Eribulin mesilate + Irinotecan hydrochloride Eisai Phase 1/2 perampanel Eisai Phase 2 rabeprazole sodium Eisai Pre-clinical Lenvatinib Eisai Phase 2 E2007 (perampanel) + E2007 (perampanel) + Placebo Eisai Phase 3 E2007 (perampanel) + E2007 (perampanel) + Placebo Eisai Phase 3 Tazemetostat Eisai Phase 2 Rufinamide Eisai Phase 3
Other Products from AbbVie